Logo image of GPRE

GREEN PLAINS INC (GPRE) Stock Fundamental Analysis

NASDAQ:GPRE - Nasdaq - US3932221043 - Common Stock - Currency: USD

4.23  +0.07 (+1.68%)

After market: 4.23 0 (0%)

Fundamental Rating

2

GPRE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 213 industry peers in the Oil, Gas & Consumable Fuels industry. GPRE may be in some trouble as it scores bad on both profitability and health. GPRE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GPRE has reported negative net income.
In the past year GPRE has reported a negative cash flow from operations.
GPRE had negative earnings in each of the past 5 years.
Of the past 5 years GPRE 4 years had a positive operating cash flow.
GPRE Yearly Net Income VS EBIT VS OCF VS FCFGPRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

GPRE has a worse Return On Assets (-6.24%) than 79.34% of its industry peers.
The Return On Equity of GPRE (-13.04%) is worse than 75.12% of its industry peers.
Industry RankSector Rank
ROA -6.24%
ROE -13.04%
ROIC N/A
ROA(3y)-5.15%
ROA(5y)-5.08%
ROE(3y)-11.53%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
GPRE Yearly ROA, ROE, ROICGPRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15 -20

1.3 Margins

The Gross Margin of GPRE (5.19%) is worse than 75.59% of its industry peers.
In the last couple of years the Gross Margin of GPRE has grown nicely.
The Profit Margin and Operating Margin are not available for GPRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.46%
GM growth 5Y30.95%
GPRE Yearly Profit, Operating, Gross MarginsGPRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

More info and screens

1

2. Health

2.1 Basic Checks

GPRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
GPRE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for GPRE has been increased compared to 5 years ago.
GPRE has a worse debt/assets ratio than last year.
GPRE Yearly Shares OutstandingGPRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
GPRE Yearly Total Debt VS Total AssetsGPRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.27, we must say that GPRE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.27, GPRE is in line with its industry, outperforming 49.30% of the companies in the same industry.
A Debt/Equity ratio of 0.71 indicates that GPRE is somewhat dependend on debt financing.
GPRE's Debt to Equity ratio of 0.71 is on the low side compared to the rest of the industry. GPRE is outperformed by 62.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z 1.27
ROIC/WACCN/A
WACC8%
GPRE Yearly LT Debt VS Equity VS FCFGPRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.38 indicates that GPRE should not have too much problems paying its short term obligations.
GPRE has a better Current ratio (1.38) than 62.91% of its industry peers.
GPRE has a Quick Ratio of 1.38. This is a bad value and indicates that GPRE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of GPRE (0.81) is worse than 61.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.81
GPRE Yearly Current Assets VS Current LiabilitesGPRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

GPRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.40%.
GPRE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.51%.
GPRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.34% yearly.
EPS 1Y (TTM)-37.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.74%
Revenue 1Y (TTM)-19.51%
Revenue growth 3Y-4.55%
Revenue growth 5Y0.34%
Sales Q2Q%0.72%

3.2 Future

The Earnings Per Share is expected to grow by 57.49% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 8.70% on average over the next years. This is quite good.
EPS Next Y21.93%
EPS Next 2Y50.94%
EPS Next 3Y43.09%
EPS Next 5Y57.49%
Revenue Next Year-0.2%
Revenue Next 2Y1.32%
Revenue Next 3Y8.55%
Revenue Next 5Y8.7%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GPRE Yearly Revenue VS EstimatesGPRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
GPRE Yearly EPS VS EstimatesGPRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 10

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GPRE. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 11.17, which indicates a very decent valuation of GPRE.
Based on the Price/Forward Earnings ratio, GPRE is valued a bit cheaper than the industry average as 61.03% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.30, GPRE is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 11.17
GPRE Price Earnings VS Forward Price EarningsGPRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GPRE indicates a slightly more expensive valuation: GPRE is more expensive than 73.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 55.96
GPRE Per share dataGPRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

GPRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GPRE's earnings are expected to grow with 43.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.94%
EPS Next 3Y43.09%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GPRE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREEN PLAINS INC

NASDAQ:GPRE (6/3/2025, 8:17:26 PM)

After market: 4.23 0 (0%)

4.23

+0.07 (+1.68%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners100.26%
Inst Owner Change-6.77%
Ins Owners2.05%
Ins Owner Change3.19%
Market Cap276.64M
Analysts72.5
Price Target9.86 (133.1%)
Short Float %13.97%
Short Ratio4.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.08
Dividend Growth(5Y)-36.76%
DP-4.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-133.26%
Min EPS beat(2)-165.14%
Max EPS beat(2)-101.38%
EPS beat(4)1
Avg EPS beat(4)-29.33%
Min EPS beat(4)-213.36%
Max EPS beat(4)362.54%
EPS beat(8)2
Avg EPS beat(8)-968.52%
EPS beat(12)3
Avg EPS beat(12)-729.5%
EPS beat(16)4
Avg EPS beat(16)-588.94%
Revenue beat(2)0
Avg Revenue beat(2)-5.86%
Min Revenue beat(2)-9.38%
Max Revenue beat(2)-2.34%
Revenue beat(4)0
Avg Revenue beat(4)-5.2%
Min Revenue beat(4)-9.38%
Max Revenue beat(4)-2.34%
Revenue beat(8)2
Avg Revenue beat(8)-3.87%
Revenue beat(12)5
Avg Revenue beat(12)-1.6%
Revenue beat(16)9
Avg Revenue beat(16)0.05%
PT rev (1m)-4.92%
PT rev (3m)-37.93%
EPS NQ rev (1m)-14.83%
EPS NQ rev (3m)-65.87%
EPS NY rev (1m)-31.27%
EPS NY rev (3m)-62.09%
Revenue NQ rev (1m)-1.02%
Revenue NQ rev (3m)-1.93%
Revenue NY rev (1m)-0.55%
Revenue NY rev (3m)1.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.17
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.35
P/tB 0.35
EV/EBITDA 55.96
EPS(TTM)-1.69
EYN/A
EPS(NY)0.38
Fwd EY8.95%
FCF(TTM)-1.9
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS37.66
BVpS12.19
TBVpS12.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.24%
ROE -13.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.19%
FCFM N/A
ROA(3y)-5.15%
ROA(5y)-5.08%
ROE(3y)-11.53%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.46%
GM growth 5Y30.95%
F-Score2
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 52.45
Cap/Depr 98.37%
Cap/Sales 3.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.81
Altman-Z 1.27
F-Score2
WACC8%
ROIC/WACCN/A
Cap/Depr(3y)148.04%
Cap/Depr(5y)157.81%
Cap/Sales(3y)4.32%
Cap/Sales(5y)5.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.74%
EPS Next Y21.93%
EPS Next 2Y50.94%
EPS Next 3Y43.09%
EPS Next 5Y57.49%
Revenue 1Y (TTM)-19.51%
Revenue growth 3Y-4.55%
Revenue growth 5Y0.34%
Sales Q2Q%0.72%
Revenue Next Year-0.2%
Revenue Next 2Y1.32%
Revenue Next 3Y8.55%
Revenue Next 5Y8.7%
EBIT growth 1Y-45.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year172.98%
EBIT Next 3Y71.18%
EBIT Next 5Y63.88%
FCF growth 1Y-83.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-129.87%
OCF growth 3YN/A
OCF growth 5YN/A